CYTOKINE LOOPS INVOLVING INTERFERON-GAMMA AND IP-10, A CYTOKINE CHEMOTACTIC FOR CD4(+) LYMPHOCYTES - AN EXPLANATION FOR THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA

被引:75
作者
SARRIS, AH
ESGLEYESRIBOT, T
CROW, M
BROXMEYER, HE
KARASAVVAS, N
PUGH, W
GROSSMAN, D
DEISSEROTH, A
DUVIC, M
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED SPECIALTIES,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL,HOUSTON,TX 77030
[3] UNIV TEXAS,HLTH SCI CTR,SCH MED,DEPT DERMATOL,HOUSTON,TX 77030
[4] INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN
[5] INDIANA UNIV,SCH MED,DEPT MICROBIOL IMMUNOL,INDIANAPOLIS,IN 46202
[6] INDIANA UNIV,SCH MED,WALTHER ONCOL CTR,INDIANAPOLIS,IN 46202
关键词
D O I
10.1182/blood.V86.2.651.bloodjournal862651
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human interferon-gamma (lFN-gamma)-inducible protein 10 (IP-10), a C-X-C chemokine, is secreted by IFN-gamma-stimulated keratinocytes and is chemotactic for CD4(+) lymphocytes. We therefore investigated its role in the epidermotropism of cutaneous T-cell lymphoma (CTCL) that is known to express IFN-gamma mRNA in the epidermis and is characterized by an indolent course with multiple relapses that remain confined to the skin for many years. By injecting purified recombinant (r) IP-10 we generated a polyclonal rabbit antiserum that specifically recognized and neutralized rIP-10. With immunoperoxidase staining, IP-10 expression was limited to the basal epidermal keratinocytes of normal skin. In biopsies of CTCL lesions the expression of IP-10 was markedly increased and it extended to the suprabasal keratinocytes in 17 of 18 patients, but it was detectable only faintly in the dermal or epidermal lymphoid infiltrates in 2 of these 18 patients. In 1 patient who had matching biopsies performed before and after treatment, IP-10 was overexpressed before treatment, but was normally expressed in the posttreatment biopsy that showed resolution of the CTCL. Increased IP-10 expression was not detected in any of 4 patients with B-cell lymphoma involving the dermis. On the basis of these findings and a review of the literature, we propose that secretion of IFN-gamma by the lymphoid infiltrate in CTCL induces the epidermal keratinocytes to secrete IP-10 that, in turn, is chemotactic for CTCL, accounting for its epidermotropism. This model may be used as a basis for future investigations of the pathogenesis of CTCL. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:651 / 658
页数:8
相关论文
共 46 条
[31]   ROLE OF INTERFERON-GAMMA IN CUTANEOUS TRAFFICKING OF LYMPHOCYTES WITH EMPHASIS ON MOLECULAR AND CELLULAR ADHESION EVENTS [J].
NICKOLOFF, BJ .
ARCHIVES OF DERMATOLOGY, 1988, 124 (12) :1835-1843
[32]  
OHMORI Y, 1993, AM J PATHOL, V142, P861
[33]   CELL-TYPE AND STIMULUS-SPECIFIC REGULATION OF CHEMOKINE GENE-EXPRESSION [J].
OHMORI, Y ;
HAMILTON, TA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (02) :590-596
[34]   PROPERTIES OF THE NOVEL PROINFLAMMATORY SUPERGENE INTERCRINE CYTOKINE FAMILY [J].
OPPENHEIM, JJ ;
ZACHARIAE, COC ;
MUKAIDA, N ;
MATSUSHIMA, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :617-648
[35]  
PANCAKE BA, 1993, N ENGL J MED, V329
[36]   ELAM-1 IS AN ADHESION MOLECULE FOR SKIN-HOMING T-CELLS [J].
PICKER, LJ ;
KISHIMOTO, TK ;
SMITH, CW ;
WARNOCK, RA ;
BUTCHER, EC .
NATURE, 1991, 349 (6312) :796-799
[37]  
PROOST P, 1993, J IMMUNOL, V150, P1000
[38]   MYCOSIS-FUNGOIDES EXHIBITS A TH1-TYPE CELL-MEDIATED CYTOKINE PROFILE WHEREAS SEZARY-SYNDROME EXPRESSES A TH2-TYPE PROFILE [J].
SAED, G ;
FIVENSON, DP ;
NAIDU, Y ;
NICKOLOFF, BJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (01) :29-33
[39]   HUMAN INTERFERON-INDUCIBLE PROTEIN-10 - EXPRESSION AND PURIFICATION OF RECOMBINANT PROTEIN DEMONSTRATE INHIBITION OF EARLY HUMAN HEMATOPOIETIC PROGENITORS [J].
SARRIS, AH ;
BROXMEYER, HE ;
WIRTHMUELLER, U ;
KARASAVVAS, N ;
COOPER, S ;
LU, L ;
KRUEGER, J ;
RAVETCH, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1127-1132
[40]   HISTOPATHOLOGIC STAGING AT INITIAL DIAGNOSIS OF MYCOSIS-FUNGOIDES AND THE SEZARY SYNDROME - DEFINITION OF 3 DISTINCTIVE PROGNOSTIC GROUPS [J].
SAUSVILLE, EA ;
EDDY, JL ;
MAKUCH, RW ;
FISCHMANN, AB ;
SCHECHTER, GP ;
MATTHEWS, M ;
GLATSTEIN, E ;
IHDE, DC ;
KAYE, F ;
VEACH, SR ;
PHELPS, R ;
OCONNOR, T ;
TREPEL, JB ;
COTELINGAM, JD ;
GAZDAR, AF ;
MINNA, JD ;
BUNN, PA .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (05) :372-382